Glasofer A, Dingley C, Kim J, Colosimo R, Gordon HRD. Medication Decision Making in Low-Income Families of Black Children With ADHD: A Mixed Methods Study.
J Atten Disord 2023;
27:847-858. [PMID:
36879501 DOI:
10.1177/10870547231158382]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/08/2023]
Abstract
OBJECTIVES
The purpose of this study was to explore how and why some low-income Black caregivers seek medication treatment for their children with ADHD.
METHODS
Using a sequential exploratory mixed method design, Phase 1 comprised an indepth case study design of seven low-income Black caregivers of children receiving medication for ADHD. Based on findings from Phase 1, the second phase involved a secondary analysis of data on Black uninsured or publicly insured children age 6 to 17 with ADHD (n = 450).
RESULTS
Factors influencing medication decision-making included child safety and volatility, caregiver mental health, caregiver aggravation, family centered care (FCC), shared decision making (SDM), sole caregiver status, and school involvement. After adjusting for ADHD severity, previous receipt of special education services and experiences of FCC and SDM were independently associated with receipt of a medication for ADHD.
CONCLUSIONS
Clinicians and school personnel can intervene to decrease disparities in the treatment of ADHD.
Collapse